Onderzoek in Ikazia - Interne geneeskunde - Boer
Publicaties internist-hematoloog mw. dr. F. de Boer
- Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
-een van de auteurs: internist-hematoloog mw. de Boer F.
Lancet Haematol. 2022 Mar;9(3):e190-e199. doi: 10.1016/S2352-3026(22)00034-5.PMID: 35240075 - Invasive fungal infections in patients treated with Bruton's tyrosine kinase inhibitors.
-een van de auteurs: internist-hematoloog mw. F. de Boer
Neth J Med. 2020 Sep;78(5):294-296.PMID: 33093256